Retinoids Promote Mouse Bone Marrow-Derived Macrophage Differentiation and Efferocytosis Via Upregulating Bone Morphogenetic Protein-2 and Smad3
Overview
Biophysics
Cell Biology
Molecular Biology
Authors
Affiliations
Clearance of apoptotic cells by bone marrow-derived macrophages differentiated from monocytes plays a central role in the resolution of inflammation, as the conversion of pro-inflammatory M1 macrophages to M2 macrophages that mediate the resolution process occurs during efferocytosis. Thus, proper efferocytosis is a prerequisite for proper resolution of inflammation, and failure in efferocytosis is associated with the development of chronic inflammatory diseases. Previous studies from our laboratory have shown that (13)-all--13,14-dihydroretinol (DHR), the product of retinol saturase, acting from day 4 of monocyte differentiation enhances the efferocytosis capacity of the resulted macrophages. Loss of retinol saturase in mice leads to impaired efferocytosis, and to development of autoimmunity. In the present paper, we report that in differentiating monocytes DHR, retinol, and all- retinoic acid all act directly on retinoic acid receptors and enhance the clearance of apoptotic cells by upregulating the expression of several efferocytosis-related genes. The effect of retinoids seems to be mediated by bone morphogenetic protein (BMP)-2, and the Smad3 transcription factor. In addition, retinoids also upregulate the expression of the vitamin D receptor and that of vascular endothelial growth factor A, indicating that altogether retinoids promote the generation of a pro-reparative M2 macrophage population during monocyte differentiation.
Kacemi R, Campos M Foods. 2025; 14(3).
PMID: 39941940 PMC: 11816923. DOI: 10.3390/foods14030347.
Adil Ali M, Garabuczi E, Tarban N, Sarang Z Sci Rep. 2023; 13(1):21001.
PMID: 38017321 PMC: 10684882. DOI: 10.1038/s41598-023-48492-9.
Stimulation of the farnesoid X receptor promotes M2 macrophage polarization.
Jaroonwitchawan T, Arimochi H, Sasaki Y, Ishifune C, Kondo H, Otsuka K Front Immunol. 2023; 14:1065790.
PMID: 36776885 PMC: 9911659. DOI: 10.3389/fimmu.2023.1065790.
Sos L, Garabuczi E, Saghy T, Mocsar G, Szondy Z Cells. 2022; 11(21).
PMID: 36359898 PMC: 9657837. DOI: 10.3390/cells11213502.
Nuclear Proteomics of Induced Leukemia Cell Differentiation.
Novikova S, Tolstova T, Kurbatov L, Farafonova T, Tikhonova O, Soloveva N Cells. 2022; 11(20).
PMID: 36291090 PMC: 9600443. DOI: 10.3390/cells11203221.